Federal contract award

68HE0221F0059

ESAT CONTRACT - TASK ORDER 005R02 LABORATORY AND ANALYTICAL SUPPORT.NON-SUPERFUND.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyEnvironmental Protection Agency
OfficeREGION 2 CONTRACTING OFFICE
NAICS541380 — Testing Laboratories and Services
PSCB504 — Chemical/Biological Studies and Analysis
Parent award / vehicle68HE0121D0001
Set-asideNot reported
Pricing typeTIME AND MATERIALS
Obligations$173.6K
Current contract value$1.1M
Potential contract value / ceiling$1.1M
Start dateJul 22, 2021
Current end dateJan 18, 2027
Potential end dateJan 18, 2027
Latest award activityAug 19, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 22 of 22 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 19, 2026P00021$15.0KESAT CONTRACT TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT, NON SUPERFUND. THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING. P00021.
Jul 7, 2026P00020$3.0KESAT CONTRACT TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT, NON SUPERFUND. THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING, EXTEND THE PERFORMANCE PERIOD, AND UPDATE THE SCA WD. P00020.
Apr 24, 2026P00019$-4.2KESAT CONTRACT TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT, NON SUPERFUND. DEOBLIGATION OF UNUSED FUNDS FROM CLINS 2001 AND 3001. P00019.
Mar 13, 2026P00018$14.9KESAT CONTRACT TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT, NON SUPERFUND. OPTION PERIOD 04, CLIN 4001. PERIOD OF PERFORMANCE 07/23/2025 TO 07/22/2026. INCREMENTAL FUNDING. P00018.
Jul 3, 2025P00017$22.0KESAT CONTRACT TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT, NON SUPERFUND. EXERCISE OPTION PERIOD 04, PERIOD OF PERFORMANCE 07/23/2025 TO 07/22/2026. P00017. (CLIN 4001). P00017.
Nov 1, 2024P00016$25.0KESAT CONTRACT TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT, NON SUPERFUND. MODIFICATION TO ADD INCREMENTAL FUNDING TO (CLIN 3001). P00016.
Jul 16, 2024P00015$0ESAT CONTRACT TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT, NON SUPERFUND. MODIFICATION TO SHIFT FUNDS IN THE AMOUNT OF $2,000.00. SHIFT FROM OPTION PERIOD 2 (CLIN 2001) AND SHIFT TO OPTION PERIOD 3 (CLIN 3001). P00015.
Jul 6, 2024P00014$10.0KESAT CONTRACT TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT, NON SUPERFUND. EXERCISE OPTION PERIOD 03, PERIOD OF PERFORMANCE 07/23/2024 TO 07/22/2025. (YR 4). P00014.
Jun 21, 2024P00013$-6.0KESAT CONTRACT TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT, NON SUPERFUND. MODIFICATION P00013. ACTION TO DE-OBLIGATE FUNDING FROM CLIN 2001, TWO ACCOUNTING STRINGS.
Dec 27, 2023P00012$6.0KESAT CONTRACT TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT, NON SUPERFUND. MODIFICATION P00012 FOR INCREMENTAL FUNDING.
Oct 27, 2023P00011$0ESAT CONTRACT TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT, NON SUPERFUND. CORRECT WORDING FROM P00010 DESCRIPTION BOX 14.
Oct 25, 2023P00010$10.0KESAT CONTRACT TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT, NON SUPERFUND. INCREMENTAL FUNDING.
Sep 21, 2023P00009$0ESAT CONTRACT TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT, NON SUPERFUND. SHIFT FUNDS ($5,288.30), TO OPTION YEAR 02 CLIN 2001 FROM OPTION YEAR 01 CLIN 1001.
Apr 27, 2023P00008$15.0KESAT CONTRACT TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT, NON SUPERFUND. EXERCISE OPTION YEAR 02, CLIN 2001.
Feb 17, 2023P00007$10.0KESAT CONTRACT - TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT - NON SUPERFUND. MOD TO ADD FUNDING TO OY01. MOD P00007 TO ADD INCREMENTAL FUNDING.
Nov 23, 2022P00006$10.0KESAT CONTRACT - TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT - NON SUPERFUND. MOD TO ADD FUNDING TO OY01.
Sep 26, 2022P00005$0ESAT CONTRACT - TASK ORDER 005R02 LABORATORY, ANALYTICAL, AND DATA VALIDATION SUPPORT - NON SUPERFUND. SHIFT FUNDS.
Jul 6, 2022P00004$8.5KESAT CONTRACT - TASK ORDER 005R02 NON-SUPERFUND ANALYTICAL AND LAB SUPPORT/DATA REVIEW. OPTION PERIOD 02.
May 18, 2022P00003$8.5KESAT CONTRACT - TASK ORDER 005R02 LABORATORY AND ANALYTICAL SUPPORT. NON-SUPERFUND. INCREMENTAL FUNDING MOD.
Feb 11, 2022P00002$6.0KESAT CONTRACT - TASK ORDER 005R02 LABORATORY AND ANALYTICAL SUPPORT. NON-SUPERFUND. INCREMENTAL FUNDING MOD.
Dec 8, 2021P00001$5.0KESAT CONTRACT - TASK ORDER 005R02 LABORATORY AND ANALYTICAL SUPPORT. NON-SUPERFUND. INCREMENTAL FUNDING MOD.
Jul 22, 20210$15.0KESAT CONTRACT - TASK ORDER 005R02 LABORATORY AND ANALYTICAL SUPPORT.NON-SUPERFUND.

Estimated positioning window

Oct 25, 2026 – Jan 23, 2027

Recompete signal:
85/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 85/100. Available recorded signals: 80 points.

Contract end 2027-01-18 (85 days from calculation)
+35 points
5 historical awards in this buyer and category group
+15 points
22 recorded award transactions
+10 points
Latest award action: 2026-08-19
+5 points
Parent award identifier recorded
+5 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.